LEADER 03111nam  2200637Ia 450 
001 9910782672903321
005 20230607222405.0
010   $a1-281-80665-X
010   $a9786611806651
010   $a0-8261-1534-9
035   $a(CKB)1000000000704997
035   $a(EBL)423414
035   $a(OCoLC)476262739
035   $a(SSID)ssj0000141551
035   $a(PQKBManifestationID)11151387
035   $a(PQKBTitleCode)TC0000141551
035   $a(PQKBWorkID)10090932
035   $a(PQKB)10130048
035   $a(MiAaPQ)EBC423414
035   $a(Au-PeEL)EBL423414
035   $a(CaPaEBR)ebr10265604
035   $a(CaONFJC)MIL180665
035   $a(EXLCZ)991000000000704997
100   $a20010918d2002      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aDrug discovery and development for Alzheimer's disease 2000$b[electronic resource] /$fHoward M. Fillit, Alan W. O'Connell, editors
210   $aNew York $cSpringer Pub Co.$dc2002
215   $a1 online resource (297 p.)
225 1 $aISOA Annual Investigators Meeting
300   $a"Papers presented at a meeting held at Tarrytown House, NY, on October 29-31, 2000, the first in a planned series entitled, "Advances in Drug Discovery and Drug Development for Cognitive Aging and Alzheimer's Disease"-- P. 3-4 of introd.
311   $a0-8261-1542-X 
320   $aIncludes bibliographical references and index.
327   $aContents; Contributors; Acknowledgments; 1 The Challenges of Drug Discovery and Drug Development for Cognitive Aging and Alzheimer's Disease; Part I. Early Detection; Part II. Drug Discovery; Part III. Drug Development-Preclinical; Part IV. Drug Development-Clinical; Index
330   $aThis prestigious volume presents the findings of an international group of academic and biotechnological researchers. Topics range from early detection programs focusing on genetic factors, novel probes for detecting B-amyloid in the living brain, and the use of telephonic screening and MRI's to the diversity of therapeutic areas such as antioxidants, estrogen agonists and various anti-B-amyloid and anti-tangle approaches. The volume is still an indispensable resource for the psychogeriatrician, psychiatrist, clinical investigator, and neurobiologist, and a must for medical libraries.
410  0$aISOA Annual Investigators Meeting
606   $aAlzheimer's disease$xChemotherapy$vCongresses
606   $aAlzheimer's disease$xChemotherapy$xEvaluation$vCongresses
606   $aDrugs$xTesting$vCongresses
615  0$aAlzheimer's disease$xChemotherapy
615  0$aAlzheimer's disease$xChemotherapy$xEvaluation
615  0$aDrugs$xTesting
676   $a616.8/31061
701   $aFillit$b Howard$01503719
701   $aO'Connell$b Alan W$01503720
712 02$aInstitute for the Study of Aging.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910782672903321
996   $aDrug discovery and development for Alzheimer's disease 2000$93732297
997   $aUNINA